Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-30 @ 4:09 AM
Study NCT ID:
NCT01013961
Status:
TERMINATED
Last Update Posted:
2023-06-28
First Post:
2009-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
E1908
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |